Inventor · disambiguated record
Yuan Chen
Also filed as: CHEN YUAN · CHEN YUAN-SHOU
14 granted patents·4 pending applications·10 citations·filing 2005–2021
85Inventor score
Files withHOPE CITY5SHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD5CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD3CHEN XIN1CHEN YUAN1
Top patents by PatentIndex Score
18 records- 0182US10100047B2Piperidine derivatives as orexin receptor antagonistSHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD·Filed 2015·Granted Oct 16, 2018·5 cites·10 claims
- 0276US9045483B2Inhibition of small ubiquitin-like modifier enzymes with substituted pyrrolo[2,3-b]quinoxalinesHOPE CITY·Filed 2013·Granted Jun 2, 2015·2 cites·3 claims
- 0375US9238654B2Singleton inhibitors of sumoylation enzymes and methods for their useHOPE CITY·Filed 2013·Granted Jan 19, 2016·2 cites·19 claims
- 0469US9791447B2Methods of identifying SENP1 inhibitorsHOPE CITY·Filed 2014·Granted Oct 17, 2017·1 cites·10 claims
- 0567US10912775B2Crystal form of orexin receptor antagonist compound, and preparation method and application thereofSHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD·Filed 2020·Granted Feb 9, 2021·0 cites·7 claims
- 0665US10874674B2Crystal form of orexin receptor antagonist compound, and preparation method and application thereofSHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD·Filed 2020·Granted Dec 29, 2020·0 cites·5 claims
- 0764US10898486B2Crystal form of orexin receptor antagonist compound, and preparation method and application thereofSHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD·Filed 2020·Granted Jan 26, 2021·0 cites·6 claims
- 0858US11041859B2Methods of identifying SENP1 inhibitorsHOPE CITY·Filed 2017·Granted Jun 22, 2021·0 cites·12 claims
- 0953US10668066B2Crystal form of orexin receptor antagonist compound, and preparation method and application thereofSHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD·Filed 2016·Granted Jun 2, 2020·0 cites·7 claims
- 1053US8796202B2Multi-valent poly-Ubl chain inhibitors and methods of useCHEN YUAN·Filed 2012·Granted Aug 5, 2014·0 cites·12 claims
- 1153US2024299405A1Application of atp potassium channel modifier in preparation of anti-diabetic nephropathy drugHANGZHOU QIAN BIOTECHNOLOGY LTD·Filed 2021·Application pending·0 cites
- 1252US11034681B2Crystal form of indole derivative and preparation method and use thereofCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2019·Granted Jun 15, 2021·0 cites·20 claims
- 1351US2024082160A1Amlodipine dry suspension and preparation method thereforGUANGZHOU APICHOPE PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 1450US2006024313A1Agents that disrupt dimer formation in DPP-IV family of prolyl dipeptidasesCHEN XIN·Filed 2005·Application pending·0 cites
- 1547US11578079B2SUMO inhibitor compounds and uses thereofHOPE CITY·Filed 2019·Granted Feb 14, 2023·0 cites·19 claims
- 1644US2023310268A1Treatment pen, main machine, and limb pain treatment instrumentYUNNAN LIHENG MEDICAL TECH CO LTD·Filed 2021·Application pending·0 cites
- 1743US10800765B2Indole derivative used as CRTH2 inhibitorCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2017·Granted Oct 13, 2020·0 cites·15 claims
- 1838US11524958B2Tricyclic compound as CRTH2 inhibitorCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2017·Granted Dec 13, 2022·0 cites·15 claims
Join the waitlist — get patent alerts
Get an alert when Yuan Chen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →